Phase 2 Autism Spectrum Disorder Trial, Recruiting NCT06129058 Sponsor: Holland Bloorview Kids Rehabilitation Hospital Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Phase 2 Autism Spectrum Disorder Trial, Recruiting

NCT06129058
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who have been diagnosed with autism spectrum disorder and have difficulties with self-regulation or social communication
  • Children who are able to take part in a brain stimulation procedure called tDCS (a non-invasive technique that uses mild electrical currents on the scalp)

Who may not be able to join:

  • Children for whom tDCS is considered unsafe, including those with a personal history of seizures, a family history of seizures, or metal implants in the body
  • Children who have other neurological conditions at the same time, such as epilepsy or a history of stroke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 416-425-6220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Registry
ClinicalTrials.gov
Start date
20 October 2023
Est. completion
30 September 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Recruitment; Attrition; Adherence; Blinding

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov